WBoehringer Ingelheim Animal Health is a multinational animal health company, formed in January 2017 when Merial was acquired by Boehringer Ingelheim and merged with Boehringer Ingelheim's existing animal health assets.
WDaiichi Sankyo Company, Limited is a global pharmaceutical company and the second-largest pharmaceutical company in Japan. It achieved JPY 2,305.4 billion in revenue in 2018. The company owns the American biotechnology company Plexxikon, the German biotechnology company U3 Pharma, and recently sold Ranbaxy Laboratories in India. Daiichi Sankyo Co., Ltd. is the producer of Benicar (Olmesartan), an angiotensin II receptor antagonist and top selling drug in the U.S. Global sales of Olmesartan in 2013 were 300.2 billion yen.
WThe Dr. B.J. Kendall Company is a historic industrial facility at 228 North Main Street in the Enosburg Falls village of Enosburgh, Vermont. Built in 1880, it was for many years the site where "Kendall's Spavin Cure", a treatment for a horse ailment, was manufactured and marketed. This business was one of the town's economic successes, its owners contributing significantly to its architectural heritage. The building was listed on the National Register of Historic Places in 1993; it presently (2016) stands vacant.
WGedeon Richter Plc. is a Hungarian multinational pharmaceutical and biotechnology company headquartered in Budapest, Hungary. It is one of the largest companies of the industry in the Central and Eastern European region and has operations in over 40 countries.
WNovartis International AG is a Swiss multinational pharmaceutical company based in Basel, Switzerland. It is one of the largest pharmaceutical companies by both market capitalization and sales.
WVirbac is a French company dedicated to animal health. It was founded in 1968 by veterinarian Pierre-Richard Dick.
WZoetis Inc. (/zō-EH-tis/) is the world's largest producer of medicine and vaccinations for pets and livestock. The company was a subsidiary of Pfizer, the world's largest drug maker, but with Pfizer's spinoff of its 83% interest in the firm it is now a completely independent company. The company directly markets the products in approximately 45 countries, and sells the products in more than 100 countries. Operations outside the United States accounted for 50% of the total revenue. Contemporaneous with the spinoff in June 2013 S&P Dow Jones Indices announced that Zoetis would replace First Horizon National Corporation in the S&P 500 stock market index.